Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 270.70M | £ 159.80M | £ 154.30M | £ 152.10M | £ 101.10M |
Total Assets | £ 2.18B | £ 1.96B | £ 1.75B | £ 1.78B | £ 1.74B |
Total Debt | £ 963.10M | £ 817.30M | £ 778.60M | £ 685.10M | £ 687.80M |
Net Debt | £ 692.40M | £ 657.50M | £ 624.30M | £ 533.00M | £ 586.70M |
Total Liabilities | £ 1.49B | £ 1.33B | £ 1.21B | £ 1.20B | £ 1.15B |
Stockholders Equity | £ 688.10M | £ 627.60M | £ 526.60M | £ 564.00M | £ 583.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |